128
Conclusion:
Our results offer a preclinical proof-of-concept
supporting a role for RET signalling inhibition in a targeted ther-
apeutic approach to improve the efficacy of EGFR inhibition in
OSCC.
http://dx.doi.org/10.1016/j.ijom.2017.02.445Surgical determinants in the outcome of oral squamous cell
carcinoma
T. Liu
∗
, M. Batstone, O. Ellis
The Royal Brisbane and Women’s Hospital, Brisbane, Australia
Background:
In our recent study, we demonstrated the associa-
tion between high-volume surgeons and larger surgical margins
. 1However, the translation of close margins to clinical outcomes
remains to be an area of controversy in the current literature.
Objectives:
To identify the surgical determinants that can improve
the treatment of patients with oral squamous cell carcinoma
(SCC).
Methods:
All oral SCC patients treated at our institution between
2008 and 2013 with a minimum of two-year follow-up were
included, while patients with contraindications for surgical man-
agement were excluded. Aheterogeneous set of predictor variables
was collected, including patient factors, surgeon factors and
tumour factors. The outcomes of interest were disease-free sur-
vival (DFS) and disease-specific survival (DSS).
Findings:
307 patients were recruited. The mean DFS and DSS
were 74.1% and 81.3%, respectively. Close and involved surgi-
cal margins were significantly correlated with surgeons who have
operated 40 cases or less during the study period (
P
= 0.0465).
On multivariate analysis, independent predictors for recurrences
were poor tumour cell differentiation (
P
= 0.0022) and perineural
invasion (
P
= 0.0003). Low-volume surgeon who operated fewer
than 20 cases was the only independent predictor for poor DSS
(
P
= 0.0001).
Conclusion:
Overall, the outcomes of oral SCC are better com-
pared to previous studies. The findings support the rationalisation
of oral SCC management at high-volume centres and in the hands
of experienced surgeons for better patient outcomes.
Reference
Ellis, O. G., David, M. C., Park, D. J., & Batstone, M. D. (2016). High-
volume surgeons deliver larger surgical margins in oral cavity cancer.
J
Oral Maxillofac Surg
,
74
, 1466–1472.
http://dx.doi.org/10.1016/j.ijom.2017.02.446Dysregulation of p63/miR-138 predicts poor prognosis in
oral cancer
X.Q. Liu
∗
, Z. Zhuang, J. Hu, P. Yu, N. Xie, C. Wang, J.S. Hou,
H.Z. Huang
Department of Oral Maxillofacial-Head and Neck Oncology, the
Affiliated Hospital of Stomatology, Guanghua School of
Stomatology, Sun Yat-sen University, Guangzhou, China
Background:
p63 is critical for the development of stratified
epithelial tissues. The role of p63 in tumourigenesis remains
poorly defined.
Objectives:
We aim to determine p63 and miR-138 expression in
oral cancers (OCs), and analyse their correlation with the clinico-
pathological parameters and prognosis in patients with OCs.
Methods:
Levels of p63 and miR-138 in OCs and noncancerous
adjacent tissues (NATs) were investigated by immunohistochem-
istry and
in situ
hybridisation, respectively. The correlations of p63
and miR-138 expression with the clinicopathological parameters
and prognosis of patients with OC were analysed. p63 and miR-
138 expression in OC cell lines was measured by immunoblot or
quantitative reverse transcriptase-polymerase chain reaction. The
effects of p63 on cell migration were evaluated by knock-in or
knock-down.
Results:
Elevated p63 and reduced miR-138 were detected in
OC tissues compared with NATs (
P
< 0.05). A negative corre-
lation between p63 and miR-138 expression can be observed in
the OC tissues. We revealed that p63 and miR-138 expression
are associated with cell differentiation, lymph metastasis status
and clinical stages in patients with OCs. Cox regression analysis
showed p63 overexpression was correlated with reduced over-
all survival. Moreover, a negative correlation between p63 and
miR-138 expression was also found in OC cell lines (
P
< 0.05).
Upregulation of p63 resulted in reduced miR-138 expression
and increased cell invasion. On the contrary, knockdown of p63
enhanced miR-138 and suppressed cell migration.
Conclusion:
The dysregulation of p63 and miR-138 are com-
mon molecular events in OC progression. These findings suggest
that p63 and miR-138 may collaboratively play a role in oral
carcinogenesis.
http://dx.doi.org/10.1016/j.ijom.2017.02.447Proposing a novel classification and staging system of
mandible osteoradionecrosis: Chinese experience
Z.L. Liu
∗
, Z.Y. Zhang, W.L. Qiu, Y. He
Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao
Tong University School of Medicine, Shanghai, China
Background:
Osteoradionecrosis (ORN) of the jaw is a common
radiation-induced complication. Several classifications and stag-
ing systems have been proposed for ORN, however, none has been
universally accepted because of their individual deficiencies.
Objectives:
The aim of this study was to introduce a new clinical
classification that can be applied to the treatment of ORN in an
easier and more acceptable way.
Methods:
A review was conducted of 99 ORN patients in our
institution between 2000 and 2013. A novel classification was
established on the basis of bone necrosis (with a cut point of 2 cm
in radiographic image, or pathological fracture) and soft tissue
defects (mucosa defect or skin fistula). A new staging system with
four different stages (stage 0, stage I, stage II, and stage III) was
proposed.
Findings:
A total of 99 patients with ORN were ultimately ana-
lysed. Radiographic analysis showed that no distinct change in
8 patients, the maximal diameter of necrotic bone >2 cm in 65
patients and that <2 cm in 14 patients, the residual 12 patients were
found with pathological fracture. Finally, 8 patients were defined
as Stage 0, 14 were classified as Stage I, 65 were categorised as
Stage II, and 12 were diagnosed as Stage III. Each stage presents
the different severity of ORN and provides suitable therapeutic
and reconstructive methods.




